Correlation Between Acumen Pharmaceuticals and Dr Reddys
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Dr Reddys Laboratories, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Dr Reddys.
Diversification Opportunities for Acumen Pharmaceuticals and Dr Reddys
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Acumen and RDY is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Dr Reddys go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Dr Reddys
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Dr Reddys. In addition to that, Acumen Pharmaceuticals is 4.47 times more volatile than Dr Reddys Laboratories. It trades about -0.01 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.07 per unit of volatility. If you would invest 1,057 in Dr Reddys Laboratories on September 4, 2024 and sell it today you would earn a total of 373.00 from holding Dr Reddys Laboratories or generate 35.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Dr Reddys Laboratories
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Dr Reddys Laboratories |
Acumen Pharmaceuticals and Dr Reddys Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Dr Reddys
The main advantage of trading using opposite Acumen Pharmaceuticals and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.| Acumen Pharmaceuticals vs. Candel Therapeutics | Acumen Pharmaceuticals vs. Cingulate Warrants | Acumen Pharmaceuticals vs. Unicycive Therapeutics | Acumen Pharmaceuticals vs. Cardio Diagnostics Holdings |
| Dr Reddys vs. Crinetics Pharmaceuticals | Dr Reddys vs. Enanta Pharmaceuticals | Dr Reddys vs. Amicus Therapeutics | Dr Reddys vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |